Antibody therapy reduces flare-ups in treatment-resistant COPD

Results come from two trials presented at European Respiratory Society International Congress Related items fromOnMedica Making sense of the new LABAs and LAMAs for COPD Physical activity decreases risk of dying in COPD End-of-life care in COPD Diagnosis of COPD needs to be improved CVD event risk raised soon after COPD exacerbations
Source: OnMedica Latest News - Category: UK Health Source Type: news